Found 471 investors
ChuangVest Ventures
China
Founded in 2015, ChuangVest Ventures is an early stage venture firm based in Shanghai, China. The firm mainly seeks to make investments in sectors like mobile commerce, industrial network, internet of things, microelectronics and biotechnology.
Venture Capital
Chuangyuan High-tech Venture Capital
China
Founded in 2010, Chuangyuan High-tech Venture Capital is the venture arm of Suzhou Chuangyuan Investment Development(Group) based in Suzhou, China. The firm seeks to make investments in industries like renewable energy, advanced materials, precision machinery, information technology, optomechatronics, biotechnology, modern service industries, etc.
Venture Capital
Chuck Vallurupalli
United States
Mr. Michael Riccio is the Founder and served as Managing Partner at Falcon Partners. He also is an Angel Investor. Prior to founding the Firm, Mr. Riccio served as Chief Operating Officer of Go2Net, Inc. (Nasdaq: GNET) until its acquisition by Infospace, Inc. (Nasdaq: INSP) in a $1.7 billion stock transaction in October 2000. As COO and a member of Go2Net's Board of Directors, Mr. Riccio had overall responsibility for Go2Net's strategic initiatives, including business development, corporate development, mergers and acquisitions, strategic investments and international business strategy. Mr. Riccio also led Go2Net's corporate venture group which co-invested with Paul Allen's Vulcan Ventures in several Internet and e-commerce companies, including AskMe, Inc., Commtouch Software, Lts. (Nasdaq: CTCH), Click2Learn, Inc. (Nasdaq: CLKS), FindWhat, Inc. (Nasdaq: FWHT) and National Discount Brokers, Inc. (acquired by Deutsche Bank). After Go2Net's sale to Infospace, Mr. Riccio became Executive Vice President of Infospace, Inc. (Nasdaq: INSP), where he had overall responsibility for Infospace's Broadband Division focused on developing broadband services and applications for PC, TV and 2.5/3G wireless platforms. Mr. Riccio was instrumental in the development and launch of the first interactive TV service offered by Bloomberg Television in 2001 and the execution of a number of strategic alliances with such companies as Microsoft, Verizon, Liberate and OpenTV. Prior to joining Go2Net in 1998, Mr. Riccio was a corporate partner at Hutchins, Wheeler & Dittmar, a Boston based law firm where he specialized in mergers and acquisitions, private equity and corporate finance. Mr. Riccio served as principal outside counsel to Lycos, Inc. from the time of the company's founding in 1995. In this capacity, he worked closely with Lycos' senior management on its initial public offering and on many subsequent strategic transactions, including the formation of the joint venture with Bertelsmann AG and the acquisitions of Angelfire, Tripod, WhoWhere? and Wired Digital. Mr. Riccio also served as counsel to a number of private equity firms including CMG@Ventures, Highland Capital Partners, Summit Partners and Thomas H. Lee Equity Partners. As counsel, he participated in transactions with a number of Internet companies, including Blaxxun Interactive, eToys, Mapquest (acquired by AOL), NextCard, PlanetAll (acquired by Amazon.com), Quote.com (acquired by Lycos), RoweCom, Silknet Software (acquired by Kana Software) and Ticketslive (acquired by Tickets.com). Mr. Riccio served as a founding partner of Xanthus Capital, L.P., a Seattle based investment firm focused on investments in emerging growth businessess, and managing partner of Vencor & Co., a Boston based investment firm focused on investing in Internet and e-commerce enterprises. He also served as interim Chief Executive Officer of Hamlet, Inc., a developer of predictive pricing solutions for the travel industry funded by Madrona Investment Group and WRF Capital. Mr. Riccio began his career as an associate in the corporate department of Willkie, Farr & Gallagher in New York. Mr. Riccio currently serves as a member of the Board of Directors of Verdiem Corp., a developer of PC power management software, and Local Lead, LLC, a provider of online lead generation services for local merchants, and as a member of the Advisory Boards of Linqware, Inc., a developer of real time collaboration software, and Integra Ventures, L.P., a venture capital partnership focused on investing in biotechnology and life sciences enterprises.
Individual/Angel
CKG Management
United States
Founded in 2016, CKG Management is a private equity firm based in Argyle, Texas. The firm seeks to invest in early-stage companies in the biotechnology sector.
Venture Capital
Clal Biotechnology Industries
Ramat Gan, Tel Aviv, Israel
Clal Biotechnology is an Israeli investment group focused on investments in biotechnology companies.
Biotechnology
Pharmaceutical
Venture Capital
Venture Capital
CMS Ventures
United Kingdom
Founded in 2020, CMS Ventures is the corporate venture arm of the China Medical System and is based in Cambridge, United Kingdom. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. It prefers to invest in the biotechnology and life sciences sector in the United Kingdom.
Venture Capital
Consorzio ARCA
Italy
Consorzio ARCA is a consortium incubator that provides industrial research, technology transfer, guidance, laboratory and training service to small and medium-sized manufacturing companies, networks and industrial districts. The firm seeks to invest in the renewable energy, sustainable building, mechatronics, environmental monitoring, remote sensing, digital technologies, management, biotechnology, human health sectors.
Accelerator
Incubator
Coronis Partners
Ness Ziona, HaMerkaz, Israel
Coronis invested in a portfolio of ten highly selected Biotechnology and Biopharmaceutical companies.
Private Equity Firm
Covid Apollo
United States
Founded in 2020, Covid Apollo is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in biotechnology and life science sectors.
Venture Capital
CTBC Capital
Taipei, T'ai-pei, Taiwan
CTBC Capital invests in information technology, communications, biotechnology, medical/healthcare, and alternative energy industries.
Corporate Venture Capital
Venture Capital
CUBIO Texas Challenge
United States
The CUBIO Texas Challenge is an accelerator program by the Cubio Innovation Center and is based in Houston, Texas. The challenge seeks to support startups from the healthcare devices, healthcare technology, biotechnology, digital health, life sciences, and wellness sectors in Texas that are looking to expand their business specifically in China.
Accelerator
Incubator
CX Venture Group
Taipei, T'ai-pei, Taiwan
CX Venture Group is a venture investment firm focusing on the technology and biotechnology industries.
Venture Capital
Dafna Capital Management
Los Angeles, California, United States
Dafna Capital Management is an investment advisor that specializes in managing client portfolios of biotechnology companies.
Venture Capital
Daniel Bragiel
United States
Mr. Rory Riggs is the Founder and serves as Chief Executive Officer at Locus. Mr. Riggs is a Co-Founder and serves as Board Member at Cibus. Mr. Riggs is also the Co-Founder and serves as a General Partner at Scientia Ventures. Mr.Riggs serves as the Chairman at eReceivables. He also is an Angel Investor. Since April 2010, Mr. Riggs has served as founder and Chief Executive Officer of Syntax Analytics, LLC, a development stage venture focused on creating a new information technology platform for large-scale portfolio management. Since June 2006, Mr. Riggs has also served as Managing Member of New Ventures, a venture fund focused on biotechnology and healthcare. Mr. Riggs has been the Managing Member of Balfour LLC, an investment management company focused on biotechnology and healthcare, since January 2001. Mr. Riggs served as the President of Biomatrix, Inc., a biomedical company, from 1996 until 2000. In addition, he was the Chief Financial Officer of Biomatrix from 1996 to 1998. He serves on the boards of directors of Royalty Pharma (Chair), Intra-Cellular Therapies, Inc., eReceivables, LLC (Chair), and GeneNews, Ltd. From 1991 to 1995, he was Chief Executive Officer of RF&P Corporation, an investment company owned by the Virginia Retirement System. He was also Managing Director of PaineWebber and Company, a stock brokerage and asset management firm, in the mergers and acquisitions field. Mr. Riggs holds a B.A. from Middlebury College, Vermont, and an M.B.A. from Columbia University.
Individual/Angel
Daniel Naor
United States
Mr. Byron Smith serves as Board Member at Preferral. He serves as Board Member at In the Bowl Animal Health. He also serves as Managing Director at Mountain Group Partners. He serves as Board Member at AngelEye Health. He served as Board Member at AgTech Accelerator. Mr. Smith currently serves on or has visitation rights to the board of directors of the following companies: NuSirt Biopharma, a company focused on developing products that combine the Company's discoveries with currently marketed and well defined pharmaceutical products that target unmet needs in our society; Silicon Ranch, a developer and operator of utility-scale solar facilities that provides turn-key renewable energy solutions to industry and utility partners; ORIG3N, a biotechnology company that collects DNA samples and researches and develops treatments for genetically inherited diseases, as well as offers a series of genetic tests that provide reports and insights on various aspects of the test-taker; AgTech Accelerator, a unique startup accelerator focused on discovering and developing emerging agricultural technology companies; Preferred, a platform designed to streamline the patient referral process; and VIDA Recovery Centers, a company that operates medication-assisted treatment clinics. Mr. Smith previously served on the board of directors of Aspire Health, a healthcare company that specializes in providing an extra layer of support to patients facing a serious illness; MedCenterDisplay, a company that installs and owns digital health networks in hospitals and other provider settings; and Myomo (NYSE:MYO), a medical device company that has developed an IP-protected custom myoelectric elbow orthotic device that enables individuals afflicted with stroke and other neuromuscular conditions to self-initiate and control movement of a partially paralyzed arm using their own muscle signals. Prior to his involvement with MGP, Mr. Smith held a long and distinguished career in the wireless and tech spaces. After receiving an MBA from the University of Chicago, Mr. Smith began his career at Procter & Gamble and PepsiCo in brand management and advertising. After eight years in packaged goods marketing, Mr. Smith transitioned into technology. First, in the early days of wireless, Mr. Smith served at Verizon (formally GTE); prior to the merger creating Verizon, all U.S. operating areas reported to him. In early 2000, Mr. Smith served as the EVP/GM and Chief Marketing Officer with Excite@Home. In Silicon Valley, Mr. Smith gained experience in media/content and internet technology/infrastructure. Mr. Smith moved home to TN in 2002 with Asurion as EVP/CMO. He led the relocation of Asurion's headquarters from Silicon Valley to Nashville. Mr. Smith was also a founding board member at The Nashville Entrepreneur Center and sits on the boards of The Trinity Forum in Washington D.C., Montgomery Bell Academy and Lost Valley Ranch in Colorado. Recently, Mr. Smith taught entrepreneurship as an adjunct professor at Vanderbilt University's Owen Graduate School of Management.
Individual/Angel
Dawson James Securities
Boca Raton, Florida, United States
Dawson James Securities is a full service investment firm specializing in healthcare, biotechnology, technology, and clean-tech sectors.
Biotechnology
CleanTech
Health Care
Venture Capital
Dechuang Investment
China
Founded in 2010, Dechuang Investment is an early and growth-stage venture capital firm based in Shanghai, China. The firm seeks to make investments in sectors like advanced materials, clean energy, biotechnology, and environmental protection industries.
Venture Capital
Deepak Gurnani
Canada
Dr. Richard Gregory serves as Board Member at ProMIS Neurosciences. In this capacity he provides leadership and direction to the Research organization and is responsible for the generation of development candidates based upon ImmunoGen's Antibody Drug Conjugate technology. Prior to ImmunoGen, Richard held a variety of roles at Genzyme and Sanofi-Genzyme, including Vice President for Gene Therapy, Head of Corporate Research and Head of R&D for the Sanofi/Genzyme R&D Center. Rich received his BSc in Biochemistry from Virginia Tech, his PhD in Biochemistry from the University of Massachusetts, and did his post-doctoral training in cancer genetics at the Worcester Foundation for Experimental Biology. He is the co-author of over 60 peer-reviewed publications and 23 issued U.S. patents in the area of biotechnology. Richard is a Fellow of the American Institute for Medical and Biological Engineering.
Individual/Angel
Deep Ventures (Venture Capital)
United States
Deep Ventures is a venture capital firm based in San Francisco, California. The firm prefers to invest in deep technology, aerospace, artificial intelligence, biotechnology, decentralization, hardware, and healthcare sectors.
Venture Capital
Diamond BioFund
Taipei, T'ai-pei, Taiwan
Diamond BioFund is a company that provides funds in life science sector, dedicated to biotechnology innovation.
Venture Capital
Showing 121 to
140 of
471 results